Emergent Biosolutions, Inc. (EBS): Price and Financial Metrics
GET POWR RATINGS... FREE!
EBS POWR Grades
- Value is the dimension where EBS ranks best; there it ranks ahead of 85.39% of US stocks.
- The strongest trend for EBS is in Growth, which has been heading down over the past 178 days.
- EBS ranks lowest in Sentiment; there it ranks in the 1st percentile.
EBS Stock Summary
- As for revenue growth, note that EBS's revenue has grown -37.47% over the past 12 months; that beats the revenue growth of just 5.63% of US companies in our set.
- The volatility of EMERGENT BIOSOLUTIONS INC's share price is greater than that of 91.49% US stocks with at least 200 days of trading history.
- EMERGENT BIOSOLUTIONS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -119.64%, greater than the shareholder yield of only 5.26% of stocks in our set.
- Stocks that are quantitatively similar to EBS, based on their financial statements, market capitalization, and price volatility, are NOVT, CSGS, PRGS, MDRX, and CRNT.
- Visit EBS's SEC page to see the company's official filings. To visit the company's web site, go to www.emergentbiosolutions.com.
EBS Valuation Summary
- EBS's price/sales ratio is 0.4; this is 91.49% lower than that of the median Healthcare stock.
- EBS's price/earnings ratio has moved down 53.6 over the prior 199 months.
Below are key valuation metrics over time for EBS.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
EBS | 2023-03-17 | 0.4 | 0.3 | -1.8 | -6.3 |
EBS | 2023-03-16 | 0.4 | 0.3 | -2.2 | -6.8 |
EBS | 2023-03-15 | 0.4 | 0.3 | -2.2 | -6.8 |
EBS | 2023-03-14 | 0.4 | 0.4 | -2.2 | -6.8 |
EBS | 2023-03-13 | 0.4 | 0.3 | -2.1 | -6.7 |
EBS | 2023-03-10 | 0.4 | 0.4 | -2.2 | -6.8 |
EBS Growth Metrics
- Its 3 year cash and equivalents growth rate is now at 217.32%.
- The 2 year cash and equivalents growth rate now stands at 139.96%.
- Its 4 year revenue growth rate is now at 115.98%.

The table below shows EBS's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 1,513.4 | 202.1 | 53.5 |
2022-06-30 | 1,602.4 | 292.8 | 96.5 |
2022-03-31 | 1,757.2 | 278.7 | 157.5 |
2021-12-31 | 1,792.7 | 321.1 | 230.9 |
2021-09-30 | 1,652.5 | 237.2 | 227 |
2021-06-30 | 1,708.7 | 325.7 | 299.2 |
EBS's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- EBS has a Quality Grade of C, ranking ahead of 50.38% of graded US stocks.
- EBS's asset turnover comes in at 0.604 -- ranking 57th of 681 Pharmaceutical Products stocks.
- ARWR, IBIO, and MCRB are the stocks whose asset turnover ratios are most correlated with EBS.
The table below shows EBS's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.604 | 0.623 | 0.227 |
2021-03-31 | 0.628 | 0.680 | 0.298 |
2020-12-31 | 0.607 | 0.663 | 0.247 |
2020-09-30 | 0.550 | 0.633 | 0.146 |
2020-06-30 | 0.536 | 0.645 | 0.152 |
2020-03-31 | 0.478 | 0.622 | 0.076 |
EBS Price Target
For more insight on analysts targets of EBS, see our EBS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $85.71 | Average Broker Recommendation | 1.69 (Moderate Buy) |
EBS Stock Price Chart Interactive Chart >
EBS Price/Volume Stats
Current price | $8.17 | 52-week high | $45.14 |
Prev. close | $8.07 | 52-week low | $8.01 |
Day low | $8.01 | Volume | 1,084,200 |
Day high | $8.31 | Avg. volume | 1,154,626 |
50-day MA | $12.55 | Dividend yield | N/A |
200-day MA | $20.07 | Market Cap | 409.64M |
Emergent Biosolutions, Inc. (EBS) Company Bio
Emergent BioSolutions is a biopharmaceutical company which develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. The company was founded in 1998 and is based in Gaithersburg, Maryland.
Latest EBS News From Around the Web
Below are the latest news stories about EMERGENT BIOSOLUTIONS INC that investors may wish to consider to help them evaluate EBS as an investment opportunity.
Emergent BioSolutions Inc. (NYSE:EBS) Q4 2022 Earnings Call TranscriptEmergent BioSolutions Inc. (NYSE:EBS) Q4 2022 Earnings Call Transcript February 27, 2023 Operator: Good day and thank you for standing by. Welcome to the Emergent BioSolutions Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer […] |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time for another breakdown of the biggest pre-market stock movers traders will want to know about on Thursday morning! |
Emergent BioSolutions Full Year 2022 Earnings: Revenues Beat Expectations, EPS LagsEmergent BioSolutions ( NYSE:EBS ) Full Year 2022 Results Key Financial Results Revenue: US$1.12b (down 38% from FY... |
Why Emergent BioSolutions Stock Tumbled by Almost 12% TodayEmergent BioSolutions (NYSE: EBS) probably wishes it had stayed in bed on Tuesday. For its fourth quarter of 2022, Emergent booked revenue of just under $331 million, which was 54% below the same quarter of the previous year. Of its two business divisions, Emergent's services unit was a real problem area. |
Emergent's (EBS) Q4 Earnings Miss, Sales Beat EstimatesEmergent (EBS) reported mixed fourth-quarter 2022 results. While the company significantly misses the mark on earnings, it beat sales estimates. |
EBS Price Returns
1-mo | N/A |
3-mo | -26.00% |
6-mo | -60.83% |
1-year | -80.79% |
3-year | -83.44% |
5-year | -84.57% |
YTD | -30.82% |
2022 | -72.83% |
2021 | -51.48% |
2020 | 66.08% |
2019 | -8.99% |
2018 | 27.57% |
Continue Researching EBS
Want to do more research on Emergent BioSolutions Inc's stock and its price? Try the links below:Emergent BioSolutions Inc (EBS) Stock Price | Nasdaq
Emergent BioSolutions Inc (EBS) Stock Quote, History and News - Yahoo Finance
Emergent BioSolutions Inc (EBS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...